When Serena Williams announced in August that she'd used Zepbound and was now a celebrity patient ambassador for telehealth company Ro, which sells GLP-1s backlash was swift, with detractors accusing Williams of everything from setting a poor example about body image to medical irresponsibility
These include Zepbound, which is an injectable form of tirzepatide approved for weight management
After 12 months, patients who underwent metabolic and bariatric surgery achieved more than 20% greater weight loss than those treated with GLP-1 therapy
I was having babies, they were having babies, right
This month alone, South Africa has seen the arrival of the first generic semaglutide, plans for lower-cost authorised versions of Ozempic, regulatory action against compounded products and a growing pipeline of generic applications before the South African Health Products Regulatory Authority (SAHPRA)
Zepbound, on the other hand, is FDA-approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, and is available in similar weekly doses